GeoVax Labs Inc【GOVX】株式ニュース

個人投資家向けのプロ仕様のツール。

プレミアム

GeoVax Receives Notice of Allowance For Cancer Vaccine Patent

Adds to Growing Portfolio of Intellectual Property Assets ATLANTA, Ga., Dec. 09, 2024 (GLOBE NEWSWIRE...

GeoVax to Present at the Noble Capital Markets Twentieth Annual Emerging Growth Equity Conference

ATLANTA, Nov. 26, 2024 (GLOBE NEWSWIRE) -- GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company...

GeoVax Announces Positive Interim Data Review for Phase 2 Clinical Trial of COVID-19 Vaccine Booster in Patients with Chronic Lymphocytic Leukemia

GEO-CM04S1 Improved Immune Response vs mRNA Vaccine ATLANTA, Nov. 19, 2024 (GLOBE NEWSWIRE) -- GeoVax...

GeoVax Reports Third Quarter 2024 Financial Results and Provides Business Update

Progress in GEO-CM04S1 BARDA/Project NextGen Phase 2b trial; multiple data readouts of existing COVID-19...

GeoVax to Report Third Quarter 2024 Financial Results and Provide Corporate Update on November 12, 2024

GeoVax to Host Conference Call at 4:30 PM ET ATLANTA, Nov. 05, 2024 (GLOBE NEWSWIRE) -- GeoVax Labs, Inc...

GeoVax to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference

ATLANTA, Ga., Oct. 02, 2024 (GLOBE NEWSWIRE) -- GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company...

GeoVax to Participate in Upcoming Investor Conferences in September

ATLANTA, GA, Sept. 03, 2024 (GLOBE NEWSWIRE) -- GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company...

Form 8-K - Current report

Form 424B5 - Prospectus [Rule 424(b)(5)]

GeoVax to Raise Approximately $5.0 Million of Gross Proceeds in Offering Priced At-the-Market

ATLANTA, GA, Aug. 28, 2024 (GLOBE NEWSWIRE) -- GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage...

Form 8-K - Current report

Form 424B5 - Prospectus [Rule 424(b)(5)]

Registration is Now Open for Tribe Public’s Webinar Event "Now Is Not the Time to Monkey(pox) Around" Featuring GeoVax Lab’s CEO

Company to Provide a Detailed Overview of Mpox Including Commentary on the Rapid Spread and Methods for...

GeoVax to Raise Approximately $8.5 Million of Gross Proceeds in Offering Priced Above-the-Market

ATLANTA, GA, Aug. 20, 2024 (GLOBE NEWSWIRE) -- GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage...

Form 4 - Statement of changes in beneficial ownership of securities

tw0122 1週前

GOVX to the bird flu rescue .. Bird Flu in Cats New Jersey
Two domestic cats in New Jersey have tested positive for the highly pathogenic avian influenza (H5N1) in Hunterdon County. One feral cat developed severe disease, including neurologic signs, and was euthanized. Another indoor-outdoor cat also tested positive, and tests on other cats on the property are pending.Additional Details:Symptoms in Cats: Clinical signs of bird flu in cats can include respiratory signs (discharge from the eyes and mouth, sneezing, coughing, difficulty breathing) and neurologic signs.Transmission: Cats can contract the virus through exposure to infected birds or other animals, contaminated environments, or by consuming raw/undercooked meat or milk from infected sources.Prevention: Pet owners are advised to avoid feeding cats raw milk or meat, avoid contact with sick or dead birds and wildlife, and thoroughly wash hands and change clothes after handling sick animals.Human Risk: While the risk of H5N1 infection to the general population remains low, close contact with infected animals can pose a risk. No human cases have been reported in New Jersey.Reporting: New Jersey residents should contact their veterinarian if they have concerns about their pets. Suspect feline cases should be reported to the New Jersey Department of Health at 609-826-4872 or zoonoticrn@doh.nj.gov.

👍️0

tw0122 2週前

$1.80s after hours with volume.

👍️0

georgie18 4週前

Nice candle on the close...🥳

👍️0

georgie18 4週前

GOVX...$1.74...🥳...Revresal Candle setting up here...

georgie18

Member Level
Re: None

Monday, January 27, 2025 12:52:55 PM

Post#
672505
of 674217
GOVX...$2.00...Scaling in on the $1.95 Dip...🥳... https://finance.yahoo.com/news/geovax-advanced-mva-manufacturing-process-140000479.html

Loaded $1.50s buyers finally trickling in having no debt offering fulfilled a few months ago and $500 million in BARDA funding this will fly once again to $10 when the big hedge fund is ready to push it again

👍️0

georgie18 1月前

GOVX...$2.00...Scaling in on the $1.95 Dip...🥳... https://finance.yahoo.com/news/geovax-advanced-mva-manufacturing-process-140000479.html

👍 1

tw0122 1月前

Bottom in low $2s as W pattern established ready for breakout soon. Could mean news

👍️ 1

tw0122 3月前

$2.74?Cancer vaccine patent awarded and remember 500 million from other studies being awarded by government low floater

GOVX....................................https://stockcharts.com/h-sc/ui?s=GOVX&p=W&b=5&g=0&id=p86431144783

👍️0

Snoop_dog 4月前

Anyone know if they working on H5N1?

GOVX...................................https://stockcharts.com/h-sc/ui?s=GOVX&p=W&b=5&g=0&id=p86431144783

👍️0

tw0122 4月前

GOVX $3.57 + 80% kept a few $1.70s.

👍️0

tw0122 4月前

GOVX $2.80s + 50%🔥🔥🔥🔥📞🚀🚀🚀🚀

👍 1 🚀 1

tw0122 4月前

Rockets fired $2.70s + 40% sold most

👍 1 🚀 1

glenn1919 4月前

govx...............................https://stockcharts.com/h-sc/ui?s=GOVX&p=W&b=5&g=0&id=p86431144783

👍 1 🚀 1

tw0122 4月前

GOVX $1:96 + 1% earnings 11-12

👍️0

tw0122 4月前

Have plenty of $1.70s financial results Nov 12 afterhours

👍️0

tw0122 5月前

Some climbing again 2.26

👍️0

PonkenPlonken 5月前

crawling out of its hole
keep on watch

👍️0

tw0122 5月前

GOVX 2.20s offshore hedgies hit some.. The government will also provide around $343M for a clinical research organization to conduct the clinical trial. Under the agreement, BARDA will award GeoVax up to $45M for the manufacturing of clinical materials and support for the Phase 2b study

👍️0

Trompete 5月前

GARBAGE, TRASH, WORTHLESS

👍️0

tw0122 5月前

$2.07 Offshore hedgies could hit here again but could be a month or two out still

👍️0

tw0122 5月前

Ok $1.90- $2s flipper

👍️0

tw0122 5月前

Confirm reversal on candle on 3rd day

👍️0

tw0122 6月前

Ok ok we see you ..but going to hold $3s this time or another fake out. Support been at $2.60s past few weeks. Looking better

👍️0

tw0122 6月前

Mpox has spread to at least 14 African countries, including Morocco, which has confirmed its first case in the current outbreak. (Source: BBC Africa)
The Democratic Republic of Congo (DRC) is the epicenter of the outbreak, with over 20,000 cases reported and more than 500 deaths. (Source: WHO)
Neighboring countries, such as Burundi, Kenya, Rwanda, and Uganda, have also reported cases. (Source: WHO)
Vaccination Efforts

The World Health Organization (WHO) recommends use of MVA-BN or LC16 vaccines, or the ACAM2000 vaccine when others are not available. (Source: WHO)
Only people at risk of exposure to mpox should be considered for vaccination, according to WHO. (Source: WHO)
Transmission and Prevention

Mpox is primarily spread through close person-to-person contact with someone who is infected, including through sex. (Source: Nature)
Cleaning and disinfecting surfaces or objects and washing hands after touching contaminated surfaces or objects can help prevent transmission. (Source: WHO)
Avoiding unprotected contact with wild animals, especially those that are sick or dead, and cooking food thoroughly can reduce the risk of getting mpox from animals. (Source: WHO)
Public Health Emergency

The WHO declared the mpox outbreak a Public Health Emergency of International Concern (PHEIC) on August 19, 2024, citing the rapid spread of a new, more transmissible strain of the virus. (Source: WHO)
Research and Development

Scientists are racing to answer questions about the outbreak, including whether vaccines will curb the spread and how the virus is transmitted. (Source: Nature)

👍️ 1

tw0122 6月前

Looking good bottom about in for hedgies

👍️0

tw0122 6月前

Watch for 2.52 - .2.92 too hold for flip. 2.08- 2.20 next zone underneath if doesn’t

👍️0

tw0122 6月前

Hedgies determine new downtrend. New entry as we see $2.80s for another flip

👍️0

tw0122 6月前

Ok hedgies confirming new upward trend perhaps give it a few hours still

👍️0

tw0122 6月前

Flip the $3.06 at 3.30s and wait for hedgies to determine direction

👍️0

tw0122 6月前

Tummies yummy $3.06 bought and then if happens to test next level down add again.
Hedgies want to take it as low as possible before the next big run into Covid vaccine season. Luv you Gary Gensler

👍️0

tw0122 6月前

Good sign 3.06 hedgies covering shorts now volume picking up 600,000. Almost time to add some more goodies

👍️0

tw0122 6月前

3.19 zone being tested if holds a few days start adding some again

👍️0

tw0122 6月前

price of $5.125 per share for expected gross proceeds of $5 million.

4:39 AM EDT, 08/29/2024 (MT Newswires) -- GeoVax Labs (GOVX) said late Wednesday it has agreed to sell 975,610 common shares in a registered direct offering to an institutional investor at a price of $5.125 per share for expected gross proceeds of $5 million.

The company will also issue warrants to purchase up to 975,610 common shares to the investor in a concurrent private placement, it said. The warrants will be exercisable at a price of $5 per share.

Net proceeds will be used for working capital and general corporate purposes, the company said.

The offering is expected to close around Friday, sub

👍️0

tw0122 6月前

Test 3.19- 3.55 zone wait to confirm before pulling trigger $2.52- 2.92 is the other zone. The hedgies that have most of the shares will determine that as they move this one as they please

👍️0

tw0122 6月前

Covid flue season blooming still holding a few here but inclined to add some more ..

GeoVax Labs, Inc. is a clinical-stage biotechnology company developing novel vaccines for many of the world’s most threatening infectious diseases and therapies for solid tumor cancers. The company’s lead clinical program is GEO-CM04S1, a next-generation COVID-19 vaccine for which GeoVax was recently awarded a BARDA-funded contract to sponsor a 10,000-participant Phase 2b clinical trial to evaluate the efficacy of GEO-CM04S1 versus an approved COVID-19 vaccine. In addition, GEO-CM04S1 is currently in three Phase 2 clinical trials, being evaluated as (1) a primary vaccine for immunocompromised patients such as those suffering from hematologic cancers and other patient populations for whom the current authorized COVID-19 vaccines are insufficient, (2) a booster vaccine in patients with chronic lymphocytic leukemia (CLL) and (3) a more robust, durable COVID-19 booster among healthy patients who previously received the mRNA vaccines. In oncology the lead clinical program is evaluating a novel oncolytic solid tumor gene-directed therapy, Gedeptin®, in a multicenter Phase 1/2 clinical trial for advanced head and neck cancers. GeoVax has a strong IP portfolio in support of its technologies and product candidates, holding worldwide rights for its technologies and products. The Company has a leadership team who have driven significant value creation across multiple life science companies over the past several decades. For more information about the current status of our clinical trials and other updates, visit our website: www.geovax.com.

👍️0

Gman3343 6月前

Going under 2.00 then time to buy.

Warrents jumped up 100%

👍️0

Biggiee 6月前

The Fauch knows how to party!

👍️0

Gman3343 6月前

Maybe the evil bastard will drop dead .

👍️0

tw0122 6月前

Buy 6.30s sell $7.30s was todays lesson dip time coming again.. Dr. Fauci Somehow Contracts Ultra-Rare West Nile Virus On Heels Of COVID-19 Infection

👍️0

Gman3343 6月前

Good, keep giving that evil idiot all my vaccines and boosters.
He should double up

👍️0

tw0122 6月前

Catch the dips play next.. Dr. Fauci has COVID again for the third time and has been vaccinated and boosted six times

👍️0

glenn1919 7月前

GOVX...............................https://stockcharts.com/h-sc/ui?s=GOVX&p=W&b=5&g=0&id=p86431144783

👍️0

tw0122 7月前

sale of 1,700,000 shares of the Company’s common stock (or common stock equivalents) at a price of $5.00 per share in a registered direct offering priced above-the-market under Nasdaq rules.
In addition, in a concurrent private placement, the Company will issue to the investor warrants to purchase up to 1,700,000 shares of common stock. The warrants have an exercise price of $5.00 per share, will be exercisable immediately following the date of issuance and will have a term of five years from the date of issuance.

👍️0

市場データ

ニュース

投資ツール

市場

発見

Hot Features

Follow Feed

ライブオプションフロー

モニター